4/23
08:42 am
ino
Inovio Pharmaceuticals: The Dilution Continues [Seeking Alpha]
Low
Report
Inovio Pharmaceuticals: The Dilution Continues [Seeking Alpha]
4/15
06:44 pm
ino
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
High
Report
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
4/15
06:39 pm
ino
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Medium
Report
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
4/5
11:02 pm
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/26
06:54 pm
ino
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine [Yahoo! Finance]
Low
Report
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine [Yahoo! Finance]
3/26
06:28 pm
ino
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
Low
Report
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
3/21
07:06 am
ino
DNA Nanotechnology Market worth $24.3 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]
Medium
Report
DNA Nanotechnology Market worth $24.3 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]
3/8
11:04 pm
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
High
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/7
10:50 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
10:24 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $11.00 price target on the stock.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $11.00 price target on the stock.
3/6
11:53 pm
ino
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
04:23 pm
ino
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
Medium
Report
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
3/6
04:05 pm
ino
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Low
Report
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
3/6
07:00 am
ino
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Low
Report
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
3/4
08:42 am
ino
Rising fears of needlestick injuries and preference for painless options propel the needle-free injection system market towards a US$ 667 million valuation by 2034 | FMI Study [Yahoo! Finance]
Low
Report
Rising fears of needlestick injuries and preference for painless options propel the needle-free injection system market towards a US$ 667 million valuation by 2034 | FMI Study [Yahoo! Finance]
2/21
08:11 am
ino
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 [Yahoo! Finance]
Medium
Report
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 [Yahoo! Finance]
2/21
08:00 am
ino
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
Medium
Report
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
2/21
07:07 am
ino
DNA Nanotechnology Market to Accumulate a Valuation of USD 29.4 Billion by 2030, Advancing at a 28.6% CAGR | MarketDigits [Yahoo! Finance]
Medium
Report
DNA Nanotechnology Market to Accumulate a Valuation of USD 29.4 Billion by 2030, Advancing at a 28.6% CAGR | MarketDigits [Yahoo! Finance]
2/20
02:14 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/12
10:05 pm
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/12
08:04 am
ino
Inovio (INO) Moves 17.4% Higher: Will This Strength Last? [Yahoo! Finance]
Medium
Report
Inovio (INO) Moves 17.4% Higher: Will This Strength Last? [Yahoo! Finance]
2/12
04:26 am
ino
Global DNA Nanotechnology Market to Reach $26.08 Billion by 2031 Owing To Growing Applications in Healthcare Sector | Says Coherent Market Insights [Yahoo! Finance]
Medium
Report
Global DNA Nanotechnology Market to Reach $26.08 Billion by 2031 Owing To Growing Applications in Healthcare Sector | Says Coherent Market Insights [Yahoo! Finance]
2/7
11:46 am
ino
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Low
Report
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2/2
08:00 am
ino
INOVIO Reports Inducement Grant Under Inducement Plan
Medium
Report
INOVIO Reports Inducement Grant Under Inducement Plan
2/2
01:05 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.